Evidence map›Paper›PMID 39185069›Full record

ArticleSAGE open medical case reports2024

Flow diversion of cerebral aneurysms in Type I osteogenesis imperfecta: A case report of the first two treatments in humans.

David A Zarrin, Jessica K Campos, Benjamen M Meyer, Alexander S Himstead, Fahad Laghari, Jonathan C Collard de Beaufort, Kiarash Golshani, Narlin B Beaty, Matthew T Bender, Geoffrey P Colby and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David A ZarrinDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0001-8666-4972
Jessica K CamposDepartment of Neurological Surgery, University of California Irvine, Orange, CA, USA.
Benjamen M MeyerCollege of Medicine, University of Arizona, Tucson, AZ, USA.
Alexander S HimsteadDepartment of Neurological Surgery, University of California Irvine, Orange, CA, USA.
Fahad LaghariCarondelet Neurological Institute, St. Joseph's Hospital, Tucson, AZ, USA.
Jonathan C Collard de BeaufortState University of New York Upstate Medical University, Syracuse, NY, USA.
Kiarash GolshaniDepartment of Neurological Surgery, University of California Irvine, Orange, CA, USA.
Narlin B BeatyFlorida State University, Tallahassee Memorial Hospital, Tallahassee, FL, USA.
Matthew T BenderDepartment of Neurosurgery, University of Rochester, Rochester, NY, USA.
Geoffrey P ColbyDepartment of Neurosurgery, University of California Los Angeles, Los Angeles, CA, USA.
Alexander L CoonCarondelet Neurological Institute, St. Joseph's Hospital, Tucson, AZ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteogenesis imperfecta (OI) predisposes individuals to easy bone fracture, vessel fragility, and platelet dysfunction. We report the first known case of neurointerventional treatment with flow diversion of intracranial aneurysms in a patient with OI. A 62 year-old female with known OI Type I, history of >40 lifetime bone fractures and hypertension, underwent workup for transient ischemic attacks revealing a 4-mm right A1 segment aneurysm in 2016. Perioperative dual antiplatelet therapy was aspirin 81 mg and clopidogrel 37.5 mg daily. Tri-axial access was utilized to deploy a 3.5 × 16-mm Pipeline Flex device without complication. Two-month follow-up revealed Raymond I (O'Kelly Marotta I) obliteration of the aneurysm. Five-year follow-up revealed a de novo left-sided 3-mm A1-A2 junction aneurysm. A 4 × 12-mm Surpass Evolve was placed without complication. Six-month follow-up revealed Raymond I (O'Kelly Marotta I) obliteration of the second aneurysm. The patient remained asymptomatic at all follow-up visits.

Indexed as

Cerebral aneurysmflow diversionosteogenesis imperfecta

Identifiers

PMID39185069
PMCPMC11344899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.